GCA
CNMD icon

Greenwood Capital Associates’s CONMED CNMD Stock Holding History

Greenwood Capital Associates’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,815
Closed -$351K – 255
2025
Q1 		$351K Sell
5,815
-47
-0.8% -$3.03K 0.05% 210
2024
Q4 		$401K Sell
5,862
-161
-3% -$11.2K 0.05% 204
2024
Q3 		$433K Sell
6,023
-118
-2% -$8.33K 0.06% 193
2024
Q2 		$426K Sell
6,141
-255
-4% -$18.6K 0.06% 196
2024
Q1 		$512K Sell
6,396
-10
-0.2% -$891 0.07% 193
2023
Q4 		$702K Sell
6,406
-154
-2% -$15.9K 0.09% 162
2023
Q3 		$662K Buy
6,560
+679
+12% +$78K 0.1% 167
2023
Q2 		$799K Sell
5,881
-268
-4% -$32.7K 0.11% 149
2023
Q1 		$639K Sell
6,149
-2,151
-26% -$208K 0.09% 171
2022
Q4 		$736K Sell
8,300
-16
-0.2% -$1.33K 0.12% 142
2022
Q3 		$667K Sell
8,316
-135
-2% -$12.7K 0.11% 154
2022
Q2 		$809K Buy
8,451
+8,344
+7,798% +$1M 0.13% 134
2022
Q1 		$16K Sell
107
-8,878
-99% -$1.24M ﹤0.01% 194
2021
Q4 		$1.27M Buy
8,985
+116
+1% +$16.4K 0.18% 100
2021
Q3 		$1.16M Buy
8,869
+36
+0.4% +$4.71K 0.18% 100
2021
Q2 		$1.21M Sell
8,833
-186
-2% -$25.5K 0.18% 93
2021
Q1 		$1.18M Sell
9,019
-624
-6% -$75.1K 0.19% 94
2020
Q4 		$1.08M Buy
9,643
+1,399
+17% +$132K 0.18% 96
2020
Q3 		$648K Buy
8,244
+1,242
+18% +$101K 0.13% 107
2020
Q2 		$504K Buy
7,002
+1,296
+23% +$90.2K 0.12% 98
2020
Q1 		$327K Buy
5,706
+1,549
+37% +$143K 0.1% 98
2019
Q4 		$465K Sell
4,157
-46
-1% -$4.9K 0.1% 115
2019
Q3 		$404K Buy
4,203
+42
+1% +$3.94K 0.1% 110
2019
Q2 		$356K Sell
4,161
-87
-2% -$7.15K 0.09% 120
2019
Q1 		$353K Sell
4,248
-181
-4% -$13.2K 0.09% 116
2018
Q4 		$284K Buy
4,429
+512
+13% +$35K 0.07% 136
2018
Q3 		$310K Buy
3,917
+18
+0.5% +$1.39K 0.07% 141
2018
Q2 		$285K Buy
+3,899
New +$265K 0.07% 143

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Greenwood Capital Associates's CNMD Position: Q2 2025 in Review

Greenwood Capital Associates sold out of CONMED (CNMD) in Q2 2025, closing a stake of 5,815 shares — an estimated $351K sold.

Greenwood Capital Associates first reported a position in CNMD in Q2 2018 and held it in 28 quarters. The position peaked at $1.27M in Q4 2021. 277 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Greenwood Capital Associates reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Greenwood Capital Associates sold 5,815 CONMED shares in Q2 2025, an estimated $351K.
  • Greenwood Capital Associates first reported a position in CONMED in Q2 2018 and held it in 28 quarters.
  • Greenwood Capital Associates's CONMED position peaked at $1.27M in Q4 2021.
  • 277 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Greenwood Capital Associates's 13F filing for Q2 2025, filed 21 Jul 2025.